Validation of the GSP<sup>®</sup>/DELFIA<sup>®</sup> Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination

Validation of the GSP<sup>®</sup>/DELFIA<sup>®</sup> Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a major global public health crisis. In response, researchers and pharmaceutical companies worked together for the rapid development of vaccines to reduce the morbidity and mortality associated with viral infection. Monitoring h...

Full description

Bibliographic Details
Main Authors: Ilaria Cicalini, Piero Del Boccio, Mirco Zucchelli, Claudia Rossi, Luca Natale, Gianmaria Demattia, Domenico De Bellis, Verena Damiani, Maria Lucia Tommolini, Erika Pizzinato, Alberto Frisco, Sara Verrocchio, Ines Bucci, Liborio Stuppia, Vincenzo De Laurenzi, Damiana Pieragostino
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
anti-SARS-CoV-2 antibody test
anti-SARS-CoV-2 vaccines
serological quantitative test
DBS
Online Access:https://www.mdpi.com/2076-393X/10/4/514

Similar Items

Similar Items